Skip to search formSkip to main contentSkip to account menu

Veglin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

VEGF-AS

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2005
2005
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2004
2004
Phase I trial of anti-sense oligonucleotide vascular endothelial growth factor (VEGF-AS, Veglin) in patients with relapsed and refractory malignancies
3008 Background: Vascular endothelial growth factor (VEGF) is critical for tumor angiogenesis and is an autocrine growth factor… 
2004
2004
Phase I trial of anti-sense oligonucleotide vascular endothelial growth factor (VEGF-AS, Veglin) in patients with relapsed and refractory malignancies.
3008 Background: Vascular endothelial growth factor (VEGF) is critical for tumor angiogenesis and is an autocrine growth factor… 
2004
2004
157 Phase I trial of an antisense to vascular endothelial growth factor (VEGF-AS, Veglin) in relapsed and refractory malignancies
Review
2004
Review
2004
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)